Your browser is no longer supported. Please, upgrade your browser.
Settings
BDSI BioDelivery Sciences International, Inc. daily Stock Chart
BDSI [NASD]
BioDelivery Sciences International, Inc.
Index- P/E- EPS (ttm)-0.28 Insider Own3.00% Shs Outstand90.75M Perf Week-5.72%
Market Cap583.52M Forward P/E20.94 EPS next Y0.31 Insider Trans-66.63% Shs Float86.99M Perf Month11.63%
Income-21.60M PEG- EPS next Q0.01 Inst Own71.10% Short Float3.53% Perf Quarter45.48%
Sales97.80M P/S5.97 EPS this Y-883.40% Inst Trans2.26% Short Ratio2.68 Perf Half Y45.80%
Book/sh0.76 P/B8.46 EPS next Y293.70% ROA-15.50% Target Price8.17 Perf Year74.73%
Cash/sh0.62 P/C10.44 EPS next 5Y25.00% ROE-45.20% 52W Range2.80 - 7.01 Perf YTD73.78%
Dividend- P/FCF- EPS past 5Y13.50% ROI-29.10% 52W High-8.27% Beta0.47
Dividend %- Quick Ratio2.00 Sales past 5Y37.40% Gross Margin81.20% 52W Low129.64% ATR0.24
Employees164 Current Ratio2.30 Sales Q/Q113.40% Oper. Margin-1.30% RSI (14)59.77 Volatility3.63% 3.90%
OptionableYes Debt/Eq0.86 EPS Q/Q101.20% Profit Margin-22.10% Rel Volume0.84 Prev Close6.49
ShortableYes LT Debt/Eq0.86 EarningsNov 12 AMC Payout- Avg Volume1.14M Price6.43
Recom1.60 SMA202.56% SMA5015.18% SMA20033.80% Volume950,333 Change-0.92%
Mar-20-19Initiated SunTrust Buy $7
Jan-31-19Resumed Janney Buy $5
Jan-26-18Initiated Seaport Global Securities Buy $5
Aug-14-17Resumed Cantor Fitzgerald Overweight $4.50
Aug-10-17Reiterated H.C. Wainwright Buy $4 → $5
May-26-17Initiated H.C. Wainwright Buy $4
May-17-17Upgrade Cantor Fitzgerald Neutral → Overweight
May-12-16Reiterated Piper Jaffray Overweight $6 → $4
May-11-16Downgrade Cantor Fitzgerald Buy → Hold
May-04-16Reiterated FBR Capital Outperform $12 → $9
Mar-14-16Reiterated Laidlaw Buy $17 → $11
Mar-11-16Reiterated FBR Capital Outperform $13 → $12
Feb-08-16Initiated Piper Jaffray Overweight
Nov-10-15Reiterated FBR Capital Mkt Perform $17 → $14
Nov-04-15Initiated Cantor Fitzgerald Buy
May-12-15Reiterated Cantor Fitzgerald Buy $17 → $12
May-11-15Reiterated ROTH Capital Buy $16 → $14
Apr-22-15Resumed Piper Jaffray Overweight
Apr-02-15Initiated FBR Capital Outperform $19
Mar-31-15Reiterated ROTH Capital Buy $18 → $16
Dec-06-19 12:00PM  What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
Dec-05-19 09:07AM  Zealand Initiates Second Late-Stage CHI Study on Dasiglucagon Zacks
Dec-04-19 11:05AM  Edited Transcript of BDSI earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
10:06AM  Zacks.com featured highlights include: Sciences International, Air Industries, Hallmark Financial Services and Vector Zacks
Dec-03-19 09:16AM  Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU Zacks
08:57AM  5 Affordable Breakout Stocks for Stunning Returns Zacks
Nov-29-19 09:13AM  BioDelivery's Belbuca Sales & Symproic Addition Encouraging Zacks
Nov-27-19 08:30AM  BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire +5.93%
Nov-25-19 08:30AM  BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors GlobeNewswire
Nov-22-19 09:48AM  The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical Zacks
Nov-20-19 10:00AM  What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
Nov-19-19 09:26AM  Protalix Finalizes Accelerated Approval Pathway for PRX-102 Zacks
Nov-14-19 10:20AM  BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View Zacks
Nov-13-19 08:00AM  IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well Zacks
07:49AM  5 Breakout Stocks for Explosive Returns Zacks
Nov-12-19 05:25PM  BioDelivery Sciences International (BDSI) Beats Q3 Earnings and Revenue Estimates Zacks
04:01PM  BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations GlobeNewswire
Nov-07-19 08:00AM  BioDelivery Sciences to Present at the 10th Annual Jefferies Global Healthcare Conference in London GlobeNewswire
Nov-06-19 05:38AM  Introducing BioDelivery Sciences International (NASDAQ:BDSI), The Stock That Zoomed 197% In The Last Three Years Simply Wall St.
Nov-05-19 10:31AM  BioDelivery Sciences International (BDSI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Nov-04-19 11:08AM  The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus Zacks
11:01AM  Zacks.com featured highlights include: Universal Forest Products, BioDelivery Sciences International, CBIZ, Euronav and The Bancorp Zacks
Nov-01-19 12:15PM  Were Hedge Funds Right About Selling BioDelivery Sciences International, Inc. (BDSI)? Insider Monkey
08:20AM  5 Stocks With Recent Price Strength to Enhance Your Return Zacks
07:45AM  5 Top Momentum Stocks in October That Still Have Upside Left Zacks
Oct-30-19 10:00AM  Here's Why Momentum Investors Will Love BioDelivery Sciences International (BDSI) Zacks
08:00AM  BioDelivery Sciences to Report Third Quarter 2019 Financial Results and Host Conference Call on November 12, 2019 GlobeNewswire
Oct-18-19 11:07AM  Moving Average Crossover Alert: BioDelivery Sciences International Zacks
08:46AM  Will BioDelivery Sciences Continue to Surge Higher? Zacks
Oct-17-19 08:57AM  New Strong Buy Stocks for October 17th Zacks
Oct-07-19 02:50PM  From Iqvia to Cree: Execs with ties to Triangle companies inked millions in Q3 stock sales American City Business Journals
Oct-01-19 08:00AM  BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic® GlobeNewswire
Sep-17-19 04:05PM  BioDelivery Sciences Announces Participation in Upcoming Investor Conferences GlobeNewswire
Sep-07-19 09:30AM  BioDelivery (BDSI) Up 8.9% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-19 08:00AM  BioDelivery Sciences Announces Upcoming Investor Conference Presentations GlobeNewswire
Aug-28-19 07:45AM  BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management GlobeNewswire
Aug-26-19 08:16PM  $572M ruling in Oklahoma opioid lawsuit could spell trouble for Triangle pharmas American City Business Journals
Aug-16-19 01:41AM  Edited Transcript of BDSI earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-19 11:55PM  BioDelivery Sciences International, Inc. (BDSI) Q2 2019 Earnings Call Transcript Motley Fool +7.94%
10:17AM  BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2 Zacks
Aug-08-19 04:05PM  BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations GlobeNewswire +6.61%
01:03PM  How Much Are BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insiders Taking Off The Table? Simply Wall St.
Aug-01-19 10:33AM  Will BioDelivery Sciences International (BDSI) Report Negative Earnings Next Week? What You Should Know Zacks +5.12%
Jul-30-19 07:45AM  BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019 GlobeNewswire
Jul-29-19 01:47PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Jul-25-19 10:15AM  Why a career Triangle pharma executive is bringing a Georgia spin-out to the region American City Business Journals
Jul-17-19 04:30AM  3 Small-Caps That Look Like Bargains at Current Trading Levels TheStreet.com
Jul-09-19 08:00AM  BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA® GlobeNewswire
Jul-03-19 02:19PM  Perrigo Completes Ranir Acquisition, Raises '19 Guidance Zacks
11:46AM  Top Ranked Momentum Stocks to Buy for July 3rd Zacks
10:22AM  Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance Zacks
Jun-28-19 02:19PM  18 Stocks Joining The Russell Indices Benzinga +5.68%
11:32AM  Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina Zacks
Jun-27-19 09:18AM  Focus on 4 Liquid Picks on the Top Rung for Robust Returns Zacks
Jun-25-19 09:00AM  What Makes BioDelivery (BDSI) a New Strong Buy Stock Zacks
Jun-24-19 08:00AM  BioDelivery Sciences Expands Upon Report from Pain Management Task Force GlobeNewswire
Jun-21-19 10:37AM  The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International Zacks
Jun-20-19 09:18AM  5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints Zacks
08:00AM  BioDelivery Sciences Named to the Russell 3000® Index GlobeNewswire
Jun-19-19 08:43PM  Heres What Hedge Funds Think About BioDelivery Sciences International, Inc. (BDSI) Insider Monkey
Jun-05-19 09:30AM  Why Is BioDelivery (BDSI) Down 12.3% Since Last Earnings Report? Zacks
May-31-19 08:33AM  Triangle company uses new financial strength to lock down favorable loan American City Business Journals
May-29-19 04:10PM  BioDelivery Sciences Announces Upcoming Investor Conference Presentations GlobeNewswire
May-28-19 04:10PM  BioDelivery Sciences Strengthens Financial Position with Debt Refinancing GlobeNewswire
07:46AM  Can You Imagine How Chuffed BioDelivery Sciences International's (NASDAQ:BDSI) Shareholders Feel About Its 108% Share Price Gain? Simply Wall St.
May-23-19 09:19AM  The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology Zacks
May-22-19 07:21AM  5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon Zacks
May-21-19 09:00AM  All You Need to Know About BioDelivery (BDSI) Rating Upgrade to Buy Zacks
May-14-19 12:50AM  Edited Transcript of BDSI earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-07-19 09:40AM  BioDelivery (BDSI) Stock Up on Q1 Earnings and Sales Beat Zacks
May-06-19 10:03PM  BioDelivery Sciences International, Inc. (BDSI) Q1 2019 Earnings Call Transcript Motley Fool
06:45PM  BioDelivery Sciences International (BDSI) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:40PM  BioDelivery: 1Q Earnings Snapshot Associated Press
04:05PM  BioDelivery Sciences Reports Strong First Quarter 2019 Results and Raises BELBUCA® Full-Year Expectations GlobeNewswire
May-02-19 10:32AM  Will BioDelivery Sciences International (BDSI) Report Negative Q1 Earnings? What You Should Know Zacks
10:11AM  What's in Store for BioDelivery (BDSI) This Earnings Season? Zacks
Apr-25-19 04:30PM  BioDelivery Sciences to Report First Quarter 2019 Financial Results GlobeNewswire
Apr-17-19 09:00AM  What Makes BioDelivery (BDSI) a New Buy Stock Zacks
Apr-13-19 09:30AM  BioDelivery (BDSI) Up 7.8% Since Last Earnings Report: Can It Continue? Zacks
Apr-11-19 10:45AM  BDSI expects $50 million in latest public offering American City Business Journals
09:34AM  BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M Zacks
09:29AM  BioDelivery Sciences International, Inc. Announces Pricing of Public Offering of Common Stock GlobeNewswire
07:48AM  The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug Benzinga
07:25AM  BDSI announces public offering after paying $30M for drug rights American City Business Journals
Apr-10-19 04:07PM  BioDelivery Sciences International, Inc. Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire
04:06PM  BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic® GlobeNewswire
Mar-27-19 05:45PM  BioDelivery Sciences International (BDSI) Dips More Than Broader Markets: What You Should Know Zacks
Mar-22-19 06:24PM  Lifshitz & Miller LLP Announces Investigation of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., and Care.com, Inc. PR Newswire
08:25AM  Edited Transcript of BDSI earnings conference call or presentation 14-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-21-19 05:45PM  BioDelivery Sciences International (BDSI) Gains But Lags Market: What You Should Know Zacks
Mar-19-19 02:26PM  Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse Zacks
Mar-18-19 06:44PM  Bristol-Myers & Pfizer Release Phase IV Data on Eliquis Zacks
Mar-15-19 10:23AM  BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up Zacks +7.79%
Mar-14-19 08:20PM  Biodelivery Sciences International Inc (BDSI) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:45PM  BioDelivery: 4Q Earnings Snapshot Associated Press
04:05PM  BioDelivery Sciences Reports Strong 2018 Results and 2019 Expectations ACCESSWIRE
02:30PM  BioDelivery Sciences International, Inc. to Host Earnings Call ACCESSWIRE
Mar-13-19 12:50PM  Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma Zacks
Mar-12-19 10:58AM  BioDelivery Sciences Investigated by Block & Leviton LLP For Violations of Federal Securities Laws GlobeNewswire -6.03%
09:59AM  Alnylam Files Application for Hypertension Candidate in UK Zacks
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer. The company also develops buprenorphine extended release injection, an injectable microparticle formulation of buprenorphine for the treatment of opioid dependence and chronic pain. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cukier HermChief Executive OfficerDec 02Option Exercise2.1838,46183,84574,842Dec 04 04:17 PM
Cukier HermChief Executive OfficerDec 02Sale6.8238,461262,30436,381Dec 04 04:17 PM
ODONNELL FRANCIS E JRDirectorDec 02Sale6.868,00054,880564,754Dec 04 04:13 PM
Broadfin Healthcare Master FunDirectorNov 18Sale5.901,793,75710,584,165300,066Nov 19 09:31 PM
Plesha Scott M.See RemarksNov 18Sale6.0625,000151,500257,336Nov 19 04:36 PM
Vollins JamesSee RemarksNov 15Option Exercise3.4629,825103,19529,825Nov 19 04:39 PM
Broadfin Healthcare Master FunDirectorNov 15Sale6.042,206,24313,319,0892,093,823Nov 19 09:31 PM
Vollins JamesSee RemarksNov 15Sale6.0929,825181,6340Nov 19 04:39 PM
Davis Todd CDirectorNov 15Sale6.11200,0001,222,000237,914Nov 19 04:38 PM
ODONNELL FRANCIS E JRDirectorNov 01Sale5.838,00046,640572,754Nov 05 04:31 PM
ODONNELL FRANCIS E JRDirectorOct 28Option Exercise3.4732,500112,775613,254Oct 30 04:33 PM
ODONNELL FRANCIS E JRDirectorOct 28Sale6.0032,500195,000580,754Oct 30 04:33 PM
Sirgo Mark ADirectorOct 18Sale5.1584,228433,7741,578,124Oct 22 04:36 PM
Sirgo Mark ADirectorOct 17Sale5.1531,860164,0791,662,352Oct 17 05:32 PM
Sirgo Mark ADirectorOct 16Sale5.158,91245,8971,694,212Oct 17 05:32 PM
ODONNELL FRANCIS E JRDirectorOct 15Option Exercise2.2632,50073,450613,254Oct 17 05:26 PM
Sirgo Mark ADirectorOct 15Sale4.98103,321514,5391,703,124Oct 17 05:32 PM
ODONNELL FRANCIS E JRDirectorOct 15Sale5.0032,500162,500580,754Oct 17 05:26 PM
ODONNELL FRANCIS E JRDirectorOct 01Sale4.348,00034,720580,754Oct 03 04:11 PM
Sirgo Mark ADirectorSep 19Sale4.7924,506117,3841,806,445Sep 19 05:02 PM
Sirgo Mark ADirectorSep 18Sale4.7743,686208,3821,830,951Sep 19 05:02 PM
Sirgo Mark ADirectorSep 17Sale4.79157,177752,8781,874,637Sep 19 05:02 PM
ODONNELL FRANCIS E JRDirectorSep 03Sale4.298,00034,320588,754Sep 04 04:08 PM
Watson W. MarkDirectorAug 13Option Exercise0.0024,739035,979Aug 15 04:29 PM
Davis Todd CDirectorAug 13Option Exercise0.0018,1230437,914Aug 15 04:27 PM
KOTLER KEVINDirectorAug 13Option Exercise0.0018,12304,300,066Aug 15 04:28 PM
Greenleaf PeterDirectorAug 13Option Exercise0.0021,144024,788Aug 15 04:25 PM
ODONNELL FRANCIS E JRDirectorAug 01Sale3.828,00030,560596,754Aug 02 04:06 PM
ODONNELL FRANCIS E JRDirectorJul 01Sale4.688,00037,440604,754Jul 03 06:00 PM
Sirgo Mark ADirectorJun 25Sale4.3990,706398,1992,031,714Jun 27 06:00 PM
Sirgo Mark ADirectorJun 12Sale4.21177,495747,2542,122,420Jun 13 06:00 PM
Sirgo Mark ADirectorJun 11Option Exercise3.6884,717311,8172,607,172Jun 13 06:00 PM
Sirgo Mark ADirectorJun 11Sale4.22307,2571,296,6252,299,915Jun 13 06:00 PM
ODONNELL FRANCIS E JRDirectorJun 03Sale4.328,00034,560612,754Jun 05 06:00 PM
Broadfin Healthcare Master FunDirectorMay 10Sale5.001,800,0009,000,0004,281,943May 14 04:58 PM
Cukier HermChief Executive OfficerMay 09Sale4.928604,23136,381May 10 06:00 PM
Cukier HermChief Executive OfficerMay 08Sale5.0729,425149,18537,421May 10 06:00 PM
ODONNELL FRANCIS E JRDirectorMay 01Sale4.778,00038,160598,254May 03 06:00 PM
Broadfin Healthcare Master FunDirectorApr 11Sale5.002,000,00010,000,0004,281,943Apr 15 04:14 PM
ODONNELL FRANCIS E JRDirectorApr 01Sale5.198,00041,520606,254Apr 03 06:00 PM
ODONNELL FRANCIS E JRDirectorMar 21Sale5.2171,690373,505614,254Mar 22 06:01 PM
Sirgo Mark ADirectorMar 21Sale5.209,05047,0602,499,955Mar 22 06:00 PM
Plesha Scott M.See RemarksMar 20Option Exercise0.0029,1660261,503Mar 22 06:02 PM
ODONNELL FRANCIS E JRDirectorMar 20Option Exercise0.0077,5000661,187Mar 22 06:01 PM
ODONNELL FRANCIS E JRDirectorMar 01Option Exercise0.0046,0000544,187Mar 01 06:43 PM
Plesha Scott M.See RemarksMar 01Option Exercise0.0011,6660224,004Mar 01 06:46 PM
ODONNELL FRANCIS E JRDirectorMar 01Sale5.0723,000116,610521,187Mar 01 06:43 PM
Sirgo Mark ADirectorJan 02Option Exercise3.059,17527,9842,498,717Jan 04 06:02 PM
Sirgo Mark ADirectorJan 02Sale3.579,17532,7552,489,542Jan 04 06:02 PM
ODONNELL FRANCIS E JRDirectorJan 02Sale3.648,00029,120506,187Jan 04 06:01 PM
Sirgo Mark ADirectorDec 27Sale2.9110,00029,1002,489,542Dec 28 06:07 PM